These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21219995)

  • 21. Micro- and nano-encapsulation of β-carotene in zein protein: size-dependent release and absorption behavior.
    Mahalakshmi L; Leena MM; Moses JA; Anandharamakrishnan C
    Food Funct; 2020 Feb; 11(2):1647-1660. PubMed ID: 32025676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study on drug release behaviors of poly-alpha,beta-[n-(2-hydroxyethyl)-L-aspartamide]-g-poly(epsilon-caprolactone) nano- and microparticles.
    Miao ZM; Cheng SX; Zhang XZ; Zhuo RX
    Biomacromolecules; 2006 Jun; 7(6):2020-6. PubMed ID: 16768428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microparticle formation and its mechanism in single and double emulsion solvent evaporation.
    Rosca ID; Watari F; Uo M
    J Control Release; 2004 Sep; 99(2):271-80. PubMed ID: 15380636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microencapsulation of
    Meira ACFO; Morais LC; Figueiredo JA; Veríssimo LAA; Botrel DA; Resende JV
    J Microencapsul; 2023 May; 40(3):171-185. PubMed ID: 36803148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Silica nanoparticle coated liposomes: a new type of hybrid nanocapsule for proteins.
    Mohanraj VJ; Barnes TJ; Prestidge CA
    Int J Pharm; 2010 Jun; 392(1-2):285-93. PubMed ID: 20363300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Depot formulation of vasoactive intestinal peptide by protamine-based biodegradable nanoparticles.
    Wernig K; Griesbacher M; Andreae F; Hajos F; Wagner J; Mosgoeller W; Zimmer A
    J Control Release; 2008 Sep; 130(2):192-8. PubMed ID: 18601963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Issues in long-term protein delivery using biodegradable microparticles.
    Ye M; Kim S; Park K
    J Control Release; 2010 Sep; 146(2):241-60. PubMed ID: 20493221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin.
    Pardakhty A; Varshosaz J; Rouholamini A
    Int J Pharm; 2007 Jan; 328(2):130-41. PubMed ID: 16997517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The robustness and flexibility of an emulsion solvent evaporation method to prepare pH-responsive microparticles.
    Nilkumhang S; Basit AW
    Int J Pharm; 2009 Jul; 377(1-2):135-41. PubMed ID: 19515519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel cryomilled physically cross-linked biodegradable hydrogel microparticles as carriers for inhalation therapy.
    El-Sherbiny IM; Smyth HD
    J Microencapsul; 2010; 27(8):657-68. PubMed ID: 21034362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Collagen-coated polycaprolactone microparticles as a controlled drug delivery system.
    Aishwarya S; Mahalakshmi S; Sehgal PK
    J Microencapsul; 2008 Aug; 25(5):298-306. PubMed ID: 18465301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microparticle size control and glimepiride microencapsulation using spray congealing technology.
    Ilić I; Dreu R; Burjak M; Homar M; Kerc J; Srcic S
    Int J Pharm; 2009 Nov; 381(2):176-83. PubMed ID: 19446625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Poloxamer 407 microspheres for orotransmucosal drug delivery. Part I: formulation, manufacturing and characterization.
    Albertini B; Passerini N; Di Sabatino M; Monti D; Burgalassi S; Chetoni P; Rodriguez L
    Int J Pharm; 2010 Oct; 399(1-2):71-9. PubMed ID: 20696227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chitosan nanoparticles encapsulated vesicular systems for oral immunization: preparation, in-vitro and in-vivo characterization.
    Jain S; Sharma RK; Vyas SP
    J Pharm Pharmacol; 2006 Mar; 58(3):303-10. PubMed ID: 16536896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and evaluation of mucinated sodium alginate microparticles for oral delivery of insulin.
    Builders PF; Kunle OO; Okpaku LC; Builders MI; Attama AA; Adikwu MU
    Eur J Pharm Biopharm; 2008 Nov; 70(3):777-83. PubMed ID: 18644444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclodextrin complexed insulin encapsulated hydrogel microparticles: An oral delivery system for insulin.
    Sajeesh S; Bouchemal K; Marsaud V; Vauthier C; Sharma CP
    J Control Release; 2010 Nov; 147(3):377-84. PubMed ID: 20727924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterisation of the barrier caused by luminally secreted gastro-intestinal proteolytic enzymes for two novel cystine-knot microproteins.
    Werle M; Kolmar H; Albrecht R; Bernkop-Schnürch A
    Amino Acids; 2008 Jun; 35(1):195-200. PubMed ID: 17619117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Collagen microparticles: preparation and properties.
    Rössler B; Kreuter J; Scherer D
    J Microencapsul; 1995; 12(1):49-57. PubMed ID: 7730956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery.
    Liu CH; Wu CT; Fang JY
    Drug Dev Ind Pharm; 2010 Jul; 36(7):751-61. PubMed ID: 20136495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The hydrogel template method for fabrication of homogeneous nano/microparticles.
    Acharya G; Shin CS; McDermott M; Mishra H; Park H; Kwon IC; Park K
    J Control Release; 2010 Feb; 141(3):314-9. PubMed ID: 19822178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.